We are live on ! Find out more
HCAT icon

Health Catalyst

1.57 USD
-0.06
3.68%
At close Updated Oct 27, 4:00 PM EDT
Pre-market
After hours
1.57
0.00
0%
1 day
-3.68%
5 days
-12.29%
1 month
-11.3%
3 months
-26.98%
6 months
14.6%
Year to date
-31.14%
1 year
-54.62%
5 years
-96.85%
10 years
-95.99%
 

About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Employees: 1,200

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 25%
Neutral 75%
Negative 0%
Neutral
GlobeNewsWire
5 days ago
Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026
SALT LAKE CITY, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its third quarter 2026 operating results on Thursday, November 5, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026
Neutral
GlobeNewsWire
1 month ago
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SALT LAKE CITY, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that on September 14, 2026, the Compensation Committee of the Company's Board of Directors granted 2,747,385 restricted stock units (the “RSUs”) to Simeon Kohl under the Health Catalyst, Inc. 2026 Employment Inducement Incentive Plan (the “Inducement Plan”) in connection with Mr. Kohl's previously announced appointment as Chief Executive Officer and President of the Company effective on September 14, 2026. The awards were granted as inducement material to Mr. Kohl's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Neutral
PRNewsWire
1 month ago
Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
Reller Joins Health Catalyst as it Enters Its Next Phase of Growth SALT LAKE CITY, Sept. 14, 2026 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst", NASDAQ: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Tami Reller has been appointed to its board of directors (Board), effective October 1, 2026.
Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
Neutral
GlobeNewsWire
1 month ago
Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
SALT LAKE CITY, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Simeon Kohl has been appointed Chief Executive Officer (CEO) and President and a member of the Company's Board of Directors, effective September 14, 2026.
Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
Neutral
GlobeNewsWire
1 month ago
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the 2026 Wells Fargo Healthcare Conference, taking place in Boston, on Wednesday, September 9, 2026 and Thursday, September 10, 2026.
Health Catalyst to Participate in Upcoming Investor Conference
Positive
MarketBeat
2 months ago
Health Catalyst Q2 Earnings Call Highlights
Health Catalyst NASDAQ: HCAT reported second-quarter 2026 revenue above the high end of its guidance range and adjusted EBITDA at the high end of its outlook, while outlining a strategic shift following the July 31 divestiture of its Vitalware and Med-Metrix businesses.
Health Catalyst Q2 Earnings Call Highlights
Neutral
Seeking Alpha
2 months ago
Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript
Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript
Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript
Positive
Zacks Investment Research
2 months ago
Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics
Positive
Zacks Investment Research
2 months ago
Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates
Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.04 per share a year ago.
Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates
Neutral
PRNewsWire
2 months ago
Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company
Company retires all credit facility debt; transaction reflects concentrating its technology on improving health system performance. SALT LAKE CITY, Aug. 6, 2026 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced it closed the sale of Vitalware, LLC, through which the Company conducted its Vitalware business, to Med-Metrix, LLC, a technology-enabled revenue cycle management company, on July 31, 2026.
Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company
Price charts implemented using Lightweight Charts™